As life sciences companies face expiring patents and shrinking drug-development pipelines, it’s never been more important to streamline the regulatory submissions process and get products to market faster. But to date, most systems for authoring, managing and submitting regulatory documents have had serious limitations in key areas for regulatory submissions professionals.